e3 Diagnostics announces it has partnered with Bertec, a Columbus, Ohio-based manufacturer of force measurement devices for clinical balance and sports performance applications. e3 will focus on distributing and servicing Bertec’s line of clinical products.
Bertec designs and manufactures Balance Advantage systems, a line of clinical systems for both assessment and treatment of balance problems.
Through this partnership, e3 Diagnostics will distribute and provide service for Bertec’s clinical balance assessment and rehabilitation solutions, including balance plates, computerized dynamic posturography equipment, and vestibular ocular reflex assessment devices, according to a media release from Bertec.
“This partnership with e3 Diagnostic makes it possible for our clinical technology to reach a broader audience, and, more importantly, gives our current and future customers access to a team of experts at a local level,” said Murat Berme, CEO of Bertec, in the release.
Bertec’s line of clinical products include:
- Computerized Dynamic Posturography (CDP/IVR) balance evaluation system to isolate and quantify impairments that contribute to a balance problem. The CDP system incorporates Immersive Virtual Reality in its distinctive dome, using computer-generated visual stimuli both for assessment and unique training environments.
- Bertec Vision Advantage (BVA), designed to evaluate vision problems resulting from head movement that can complicate balance performance by identifying dysfunction in the vestibular ocular reflex (VOR) per the Dynamic Visual Acuity (DVA) Test. It also measures the head velocity, axis, and direction where visual accuracy breaks down per the Gaze Stabilization Test (GST).
- Portable Essential balance assessment solution for use in environments such as community outreach, satellite offices, and high-volume screening applications.
- COBALT, a balance test for athletes. COBALT can be used as part of a concussion screening and management program by providing an objective measurement of balance control when relying on visual, somatosensory, and vestibular demands.
“E3 Diagnostics is continually looking to add to its portfolio of product and service solutions for its customers, and we’re thrilled to be partnering with the leading manufacturer of balance assessment and treatment products,” said Don Williams, president of e3 Diagnostics, in the release. “With the recent discontinuation of the Natus NeuroCom line, e3 is excited to be able to help our customers seeking to expand or upgrade their balance-based equipment.”
[Source(s): Bertec, PRWeb]